Decidual vasculopathy in preeclampsia 3A: Prediction and early detection (pilot study)

Recruiting

• Conditions: HELLP syndrome; preeclampsia; 10026908; 10057166

• Registration Number: NL-OMON35575
• Lead Sponsor: niversitair Medisch Centrum Sint Radboud

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 70

Inclusion Criteria

Patients who are admitted at Radboud University Nijmegen Medical Centre with the diagnosis of preeclampsia.

Exclusion Criteria

Multiple pregnancies, signs of intra-uterine infection, chomosomal abnormalities of the fetus.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Levels of biomarkers and bilateral uterine artery flow in multiples of the<br /><br>median (for details see page 12 of research protocol).</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Levels of biomarkers in multiples of the median (for details see page 12 of<br /><br>research protocol)</p><br>